Atossa Genetics Inc Share Price Nasdaq
Equities
US04962H1005
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 208M 17.36B |
---|---|---|---|---|---|
Net income 2024 * | -35M -2.92B | Net income 2025 * | -39M -3.26B | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-6.09
x | P/E ratio 2025 * |
-5.72
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.9% |
Latest transcript on Atossa Genetics Inc
Managers | Title | Age | Since |
---|---|---|---|
Shu-Chih Chen
FOU | Founder | 62 | 01/08/01 |
Steven Quay
CEO | Chief Executive Officer | 73 | 01/08/01 |
Heather Rees
DFI | Director of Finance/CFO | - | 01/17/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Steven Quay
CEO | Chief Executive Officer | 73 | 01/08/01 |
Director/Board Member | 66 | 01/14/01 | |
H. Remmel
BRD | Director/Board Member | 72 | 01/12/01 |
1st Jan change | Capi. | |
---|---|---|
+20.79% | 47.9B | |
+46.56% | 41.42B | |
-2.61% | 40.7B | |
-6.20% | 28.92B | |
+10.21% | 25.55B | |
-21.83% | 19.27B | |
-2.00% | 12.15B | |
+30.77% | 12.14B | |
-0.82% | 11.99B |